NCT00367809

Brief Summary

The Wellness Interventions after Transplant (WIAT) Trial has reached its enrollment target. This trial is no longer recruiting new patients. Those currently enrolled will be followed for a year to evaluate trial outcomes. The purpose of this trial is to determine if training in Mindfulness-Based Stress Reduction can reduce symptom distress and improve quality of life in solid organ transplant recipients. Primary study outcomes are depression, anxiety and insomnia symptoms, measured by well-validated self-report scales. The impact of this program on objectively measured sleep outcomes, use of health care resources and costs will also be evaluated.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
140

participants targeted

Target at P25-P50 for phase_3

Timeline
Completed

Started Aug 2003

Longer than P75 for phase_3

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2003

Completed
3.1 years until next milestone

First Submitted

Initial submission to the registry

August 21, 2006

Completed
2 days until next milestone

First Posted

Study publicly available on registry

August 23, 2006

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2008

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2008

Completed
Last Updated

September 16, 2008

Status Verified

September 1, 2008

Enrollment Period

4.8 years

First QC Date

August 21, 2006

Last Update Submit

September 12, 2008

Conditions

Keywords

MeditationMindfulnessOrgan TransplantTransplantationMinnesotaImmune suppressive therapy

Outcome Measures

Primary Outcomes (3)

  • Reduction in depression

    Baseline; at 8 weeks, at 6- and 12- months

  • anxiety

    Baseline; at 8 weeks, at 6- and 12- months

  • insomnia

    Baseline; at 8 weeks, at 6- and 12- months

Study Arms (3)

1

EXPERIMENTAL
Behavioral: Mindfulness-Based Stress Reduction (MSBR)

2

ACTIVE COMPARATOR
Behavioral: Health Education (HE)

3

NO INTERVENTION
Behavioral: Delayed Intervention

Interventions

Mindfulness-Based Stress Reduction (MBSR) is the intervention of primary interest. It is a psycho-educational program of 8-weekly classes, 2.5 hours long taught by a trained instructor. Over the course of the program participants receive training in several formal meditation techniques: a body-scan meditation, sitting meditation, walking meditation and mindful Hatha yoga that involves simple stretches and movements. Participants are requested to practice meditation at home and to integrate informal mindfulness practices into their daily lives. The content of MBSR is described in the book Full Catastrophe Living by Jon Kabat-Zinn.

1

The active control condition was a peer-led chronic disease self-management program comprised of 8 weekly, 2.5 hour meetings. Led by trained peer-leaders, groups of participants discussed health challenges and problem-solved using a technique called action-planning. The curriculum described by Lorig and colleagues in the book Living a Health Life was the core of this program, and transplant-specific issues were covered in two meetings to match MBSR for time and attention.

2

A temporary wait-list control group; after 6 months, those in the Delayed Intervention were randomized a second time, to one of the active treatment arms (MBSR or HE).

3

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • kidney, kidney/pancreas, pancreas, lung, liver, heart or heart-lung recipients, with a functioning graft
  • years old or older
  • English-speaking
  • literate
  • mentally intact
  • reachable by telephone
  • on immune suppressive medication
  • receiving regular medical follow-up care
  • interested in health promotion and mind-body interventions
  • able to attend weekly classes in a Minnesota Metro area
  • willing to complete the informed consent process

You may not qualify if:

  • serious preexisting mental health issues such as suicide attempts or a psychosis
  • medically unstable (a hospital admission for non-elective purposes in the last 3 months or major surgery planned in the next 3 months)
  • on dialysis
  • regularly practicing mindfulness meditation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Minnesota Academic Health Center

Minneapolis, Minnesota, 55404, United States

Location

Related Publications (4)

  • Gross CR, Kreitzer MJ, Russas V, Treesak C, Frazier PA, Hertz MI. Mindfulness meditation to reduce symptoms after organ transplant: a pilot study. Altern Ther Health Med. 2004 May-Jun;10(3):58-66.

    PMID: 15154154BACKGROUND
  • Kreitzer MJ, Gross CR, Ye X, Russas V, Treesak C. Longitudinal impact of mindfulness meditation on illness burden in solid-organ transplant recipients. Prog Transplant. 2005 Jun;15(2):166-72. doi: 10.1177/152692480501500210.

  • Gross CR, Kreitzer MJ, Thomas W, Reilly-Spong M, Cramer-Bornemann M, Nyman JA, Frazier P, Ibrahim HN. Mindfulness-based stress reduction for solid organ transplant recipients: a randomized controlled trial. Altern Ther Health Med. 2010 Sep-Oct;16(5):30-8.

  • Gross CR, Kreitzer MJ, Reilly-Spong M, Winbush NY, Schomaker EK, Thomas W. Mindfulness meditation training to reduce symptom distress in transplant patients: rationale, design, and experience with a recycled waitlist. Clin Trials. 2009 Feb;6(1):76-89. doi: 10.1177/1740774508100982.

MeSH Terms

Interventions

Mindfulness-Based Stress Reduction

Intervention Hierarchy (Ancestors)

MindfulnessCognitive Behavioral TherapyBehavior TherapyPsychotherapyBehavioral Disciplines and Activities

Study Officials

  • Dr. Cynthia Gross

    University of Minnesota

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
NONE
Intervention Model
PARALLEL
Sponsor Type
NIH

Study Record Dates

First Submitted

August 21, 2006

First Posted

August 23, 2006

Study Start

August 1, 2003

Primary Completion

May 1, 2008

Study Completion

May 1, 2008

Last Updated

September 16, 2008

Record last verified: 2008-09

Locations